Ibrutinib increases the risk of atrial fibrillation, potentially through inhibition of cardiac PI3K-Akt signaling.

Blood

Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.

Published: December 2014

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-604272DOI Listing

Publication Analysis

Top Keywords

ibrutinib increases
4
increases risk
4
risk atrial
4
atrial fibrillation
4
fibrillation inhibition
4
inhibition cardiac
4
cardiac pi3k-akt
4
pi3k-akt signaling
4
ibrutinib
1
risk
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!